T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to heal fatty liver in diabetics
Disease control Not yet recruitingThis study is testing whether a new drug called chiglitazar, when added to standard liver-protecting vitamins, can help treat a serious fatty liver disease (MASH) in people who also have type 2 diabetes. It will involve 300 adults who have both conditions. Participants will take …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 02, 2026 03:57 UTC
-
New Triple-Threat pill aims to tame diabetes
Disease control Not yet recruitingThis study is testing a new once-daily pill that combines three different diabetes medications. It aims to see how well it works and how safe it is for controlling blood sugar in 300 Chinese adults with Type 2 diabetes. The study will follow patients for 24 weeks to measure chang…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test new diabetes pill formula on healthy volunteers
Disease control Not yet recruitingThis study aims to see if a new extended-release pill containing two diabetes drugs (chiglitazar and metformin) works the same way in the body as a reference version. It will involve 24 healthy volunteers who will take each pill once during the study. The main goal is to compare …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Could a One-Time procedure reset your Body's sugar control?
Disease control Not yet recruitingThis study is testing a new, one-time endoscopic procedure called ReCET for people whose type 2 diabetes is not well-controlled with pills. The goal is to see if treating the first part of the small intestine (duodenum) can improve blood sugar levels and reduce fat in the liver. …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope to halt kidney damage in diabetics
Disease control Not yet recruitingThis study is testing whether adding a medication called ganagliflozin to standard treatment can help slow the worsening of kidney disease in people who have both type 2 diabetes and chronic kidney disease. About 1,244 participants will take either ganagliflozin or a placebo (ina…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC